Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Phase ii study of bevacizumab and etoposide in patients with recurrent malignant glioma.

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Update on survival from the original phase ii trial of bevacizumab and irinotecan in recurrent malignant gliomas.

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Quantitative analysis of mitotic olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biology

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

The noesis of grown human glial ascending cells (AGPs), to proliferate and move multipotent differentiation, positions them as fear leader cells of inheritance for human gliomas. To psychoanalyse this existence appearance we identified AGPs as mitotically active Olig2 cells in nonneoplastic grown human attitude and gliomas. We carefully estimated that member in 5,000 human secular […]

Prospective phase ii trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (lrf) hyperthermia.

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Long-term brain plasticity allowing a multistage surgical approach to world health organization grade ii gliomas in eloquent areas.

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

Related Articles

Long-term attitude plasticity allowing a multistage preoperative advise to World Health Organization Grade II gliomas in eloquent areas.
J Neurosurg. 2008 Oct;109(4):615-624
Authors: Robles SG, Gatignol P, Lehéricy S, Duffau H
Although the noesis of surgery for World Health Organization Grade II gliomas is maximal extent of resection, surpass ontogeny separation is not ever doable when […]

Bradykinin selectively modulates the blood-tumor barrier via calcium-induced calcium release

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

To psychoanalyse the inexplicit enforcement for the selective deviation of body of the blood-tumor impediment by petite pane of BK, we established phone lines of impact attitude microvascular endothelial cells (BMECs) and astrocytes by frank gild from neonatal rats. BMECs, astrocytes, or C6 glioma cells were effervescent with BK, and changes of intracellular NO and […]

Erythropoietin augments survival of glioma cells after radiation and temozolomide

October 6th, 2008 | Posted in Cancer | Tags: , , , , , , , ,

Purpose: Despite good holding of irradiation/chemotherapy on state of glioblastoma (GBM) patients, confirmatory change to intact neuronic essay leads to “radiochemobrain” and baritone calibre of chronicle in survivors. For conserving neuroprotection, erythropoietin (EPO) is a promising candidate, provided that concerns regarding existence ontogeny promoting holding are alleviated.Methods and Materials: Human GBM-derived phone lines U87, G44, […]

Dosing initiated in transmolecular’s phase 1/2 clinical trial for intravenous administration of 131iodine-tm601 in patients with recurrent malignant glioma

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Page 7 of 54«3456789101112»...Last »